Ajanta Pharma gets CDSCO Panel nod to study Tadalafil Oral Jelly for erectile dysfunction Dr. Divya Colin3 Jan 2023 12:00 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
Ajanta Pharma Promoter entities sell 4.3 percent stake for Rs 637 crore Ruchika Sharma24 Dec 2022 4:30 AM GMTNew Delhi: Promoter entities of Ajanta Pharma has divested 4.3 percent stake in the company for Rs 637 crore through open market transactions. The...
Ajanta Pharma conferred as "Best Managed Companies" in India by Deloitte Ruchika Sharma18 Oct 2022 9:00 AM GMTMumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, has been awarded as "Best Managed Companies" in India by Deloitte for 2022. ...
Ajanta Pharma Dahej facility gets 2 procedural observations from USFDA Ruchika Sharma13 Sep 2022 6:45 AM GMTThe formulation facility was inspected by USFDA from 5th September 2022 to 9th September 2022.
Ajanta Pharma board nod to Rs 286-crore share buyback plan Ruchika Sharma29 Dec 2021 5:30 AM GMTNew Delhi: Drug firm Ajanta Pharma on Tuesday said its board has approved a share buyback plan of up to Rs 286-crore, wherein the drug maker...
NPPA panel fixes MRP of Ajanta Pharma Metoprolol Tartrate, lvabradine Hydrochloride FDC Medical Dialogues Team15 Oct 2021 6:25 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the price of the Fixed Dose Combination (FDC) of each film coated...
Ajanta Pharma lines up capex plan of Rs 250 crore for FY22 Ruchika Sharma10 May 2021 8:31 AM GMTNew Delhi: Drug maker Ajanta Pharma has lined up a capex plan of Rs 250 crore for the current fiscal as it looks to expand its corporate office and...
ABCD Technologies onboards 9 new investors including Glenmark, Alembic pharma Medical Dialogues Team5 May 2021 7:17 AM GMTNew Delhi: With the aim of building the IT infrastructure and supply chain required for pharmaceutical distribution, ABCD Technologies LLP (to be...
Ajanta Pharma net profit up 23 percent at Rs 159 crore in Q4 Ruchika Sharma2 May 2021 3:30 AM GMTNew Delhi: Drug firm Ajanta Pharma on Friday reported a 23 per cent rise in consolidated net profit to Rs 159 crore for the quarter ended March...
Ajanta Pharma net profit rises 64 percent to Rs 177 crore in Q3 Ruchika Sharma4 Feb 2021 3:30 AM GMTNew Delhi: Drug firm Ajanta Pharma on Tuesday reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December...
Ajanta Pharma launches generic asthma drug in US market Pooja Bhatia Bhatia17 Nov 2015 4:33 AM GMTNew Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US...
